Zimbabwe - Press Releases

LOS ANGELES, March 16, 2025 /PRNewswire/ -- The National Council for Incarcerated and Formerly Incarcerated Women and Girls regrets that Elizabeth Oyer is no longer the U.S. Pardon Attorney. We thank her for her exemplary service. In three years, Ms. Oyer achieved reforms people did not think possible. She reduced the mind-boggling 18,000 application backlog to 3,000 while new applications continued to pour in. She revamped the application forms to make them user-friendly. She made it possible for people to explain extenuating circumstances such as domestic abuse or drug addiction when discussing their transgressions. She traveled to prisons to meet with incarcerated people and had an open-door policy for advocates. Her record of service is extraordinary.

Bioretec Ltd Press Release 14 March 2025 at 7:00 p.m. EET

Bioretec LtdCompany announcement14 March 2025 at 7:30 p.m. EET

Bioretec LtdCompany announcement14 March 2025 at 7:30 p.m. EET

BRIDGEWATER, N.J., March 14, 2025 /PRNewswire/ --Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration(FDA) to advance the manufacturing and delivery of its vaccine portfolio for the 2025-26 flu season in the US. As the world leader in flu vaccines, Sanofi had already begun its annual production of vaccines to ensure that robust supply is ready for the coming season. Strains selected by the FDA match those already used in production by the company to help protect eligible patients against flu and its potentially severe complications.

Sunmed | Your CBD Store Calls for Transparency as Lawmakers Push Undisclosed Amendments

WASHINGTON, March 14, 2025 /PRNewswire/ -- The Human Animal Bond Research Institute (HABRI) and Pet Partners today announced the publication of an important study showing significant reductions in child and parental anxiety and the reduced need for anxiety medication resulting from therapy dog visits in the emergency department. This study, published inJAMA Network was led by Jeffrey A. Kline, MD, Associate Chair of Research at the Department of Emergency Medicine at Wayne State University School of Medicine.

SILVER SPRING, Md., March 14, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

DENVER, March 14, 2025 /PRNewswire/ -- Espire Dental, a fast-growing, elite, cosmetic and multi-specialty group practice, founded by dentists, is pleased to announce a new partnership with Zollege, which operates Dental Assistant Schools throughout the state which are approved and regulated by the Colorado Department of Higher Education, Private Occupational School Board. This new collaboration expands access to a 12-week, hands-on training Dental Assisting Program that prepares aspiring dental assistants for rewarding careers without the burden of heavy student debt.

GAINESVILLE, Fla, March 14, 2025 /PRNewswire/ -- iOncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunotherapy platform technologies, today announced the acquisition of TargImmune Therapeutics, a biotechnology company specializing in novel tumor targeted immunotherapies. This strategic acquisition significantly enhances iOncologi's capabilities in developing cutting-edge immunotherapies for solid tumors.

SIMI VALLEY, Calif., March 14, 2025 /PRNewswire/ -- Adventist HealthSimi Valley is proud to announce the opening of its newly designed clinic, a major step forward in providing high-quality, accessible healthcare to the community.This new facility combines two former clinics into one streamlined location, increasing efficiency, improving patient flow, and expanding access to primary and specialty care.

Skyhawk presents today on its novel SKY-0515 small molecule RNA splicing modulator targeting Huntington's Disease to members of the Huntington's Disease Youth Organization, at the annual HYDO International Congress in Prague, Czech Republic.

The Series C financing was led by a global strategic investor along with participation from new investors Aphelion Cardeation and Unorthodox Ventures. Existing investors Engage Venture Partners, JWC Venture and Features Capital also participated in the round. Laplace Interventional plans to use the funds raised from this round towards completing their Early Feasibility Study (EFS) and work towards a pivotal study approval.

PERTH, Australia, March 16, 2025 /PRNewswire/ -- ArgentBioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology, is pleased to announce positive Phase IIb clinical trial results for CimetrA, a novel anti-inflammatory treatment. The study confirmed CimetrA's strong safety profile and demonstrated faster recovery times in COVID-19 patients.

CANTON, Conn., March 17, 2025 /PRNewswire/ -- Kelyniam Global (OTC:KLYG), a manufacturer of custom cranial implants, has announced its financial results for the year ended December 31, 2024.

BLOOMFIELD HILLS, Mich., March 14, 2025 /PRNewswire/ --Woodward Park Partners is pleased to announce that its client Federal Civil Group, LLC ("Federal Civil Group", or the "Company") has acquired F. Allied Construction, Inc. ("Allied Construction"), a leading asphalt paving company providing residential and commercial paving, repairs and maintenance services throughout Southeast Michigan. The acquisition of Allied Construction, combined with Federal Civil Group's existing subsidiaries Federal Paving and State Crushing, will enable the Company to provide a comprehensive service offering of paving maintenance solutions to its customers throughout Southeast Michigan.

VANCOUVER, March 14, 2025 /PRNewswire/ -- City OfficeREIT, Inc. (NYSE: CIO) ("City Office," "CIO" or the "Company") announced today that its Board of Directors has authorized a quarterly dividend amount of $0.10 per share of common stock and common unit of partnership interest for the first quarter of 2025.

THE WOODLANDS, Texas, March 14, 2025 /PRNewswire/ -- Sterling Infrastructure, Inc. (NasdaqGS: STRL) ("Sterling" or "the Company") today announced the appointment of Ronald A. Ballschmiede, the Company's Executive Vice President, as Sterling's interim Principal Financial Officer and Principal Accounting Officer, effective March 14th. Mr. Ballschmiede assumes this position following the departure of Sharon Villaverde to pursue other opportunities. Mr. Ballschmiede served as Sterling's Chief Financial Officer and Chief Accounting Officer from November 2015 to May 2024, and has held the role of Executive Vice President from 2015 through the present. The Company has initiated a formal search process to identify a permanent Chief Financial Officer.

COLUMBUS, Ohio, March 14, 2025 /PRNewswire/ --M/I Homes, Inc. (NYSE:MHO) today announced that Friedrich K.M. Bhm, an independent member of the Company's Board of Directors since 1994, has informed the Company of his decision to retire from the Board upon the expiration of his term, and not stand for re-election, at the Company's 2025 Annual Meeting of Shareholders. The Company will identify the Board of Directors' nominee to serve on the Board as Mr. Bhm's successor in the Company's Proxy Statement for its 2025 Annual Meeting of Shareholders.

DALLAS, March 14, 2025 /PRNewswire/ -- VineBrook Homes Trust, Inc. announced today that the record date for determining stockholders entitled to vote at the 2025 Annual Meeting of Stockholders (the "Annual Meeting") will be Monday, March 31, 2025. The Annual Meeting will be held on Tuesday, June 10, 2025, beginning at 10:00 a.m. Central Time. The Annual Meeting will be held exclusively through a virtual format. Stockholders will not be able to attend the Annual Meeting in person, however stockholders of record as of the close of business on March 31, 2025, will be able to vote and ask questions during the Annual Meeting through the online platform.

The deal will send a combined 60 Casitas to South Carolina and California, with plans for further expansion.

WASHINGTON, March 14, 2025 /PRNewswire/ -- Four crew members of NASA's SpaceX Crew-10 mission launched at 7:03 p.m. EDT Friday from Launch Complex 39A at NASA's Kennedy Space Center in Florida for a science expedition aboard the International Space Station.

NEW YORK, March 15, 2025 /PRNewswire/ -- NYR.com// -- Want to live in a building designed by the architect who created the Pyramid of the Louvre, or the National Gallery in Washington? Nestled in the heart of New York City at 33 West 56th Street, The Centurion stands as a testament to architectural brilliance and luxury. Designed by the legendary Pritzker Prize-winning architect I.M. Pei and his son, Sandi Pei, this exclusive condominium offers a unique blend of classic elegance and contemporary design. Among its distinguished residences, Penthouse D emerges as a paragon of sophistication and comfort, and now is available for sale and immediate occupancy.

NORTH CHICAGO, Ill., March 15, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE (mirvetuximab soravtansine-gynx) in women with folate receptor alpha (FR)-positive platinum-resistant ovarian cancer (PROC) compared to chemotherapy. At 30.5 months median follow-up, treatment with ELAHERE continued to show significant improvements in progression-free survival (PFS) and overall survival (OS) compared to investigator's choice (IC) chemotherapy.1 Ovarian cancer patients often present with late-stage disease and are historically first treated with platinum-based chemotherapy, which they may become resistant to and require another therapy, such as ELAHERE.2

SIMI VALLEY, California, 15 de marzo de 2025 /PRNewswire-HISPANIC PR WIRE/ -- Adventist Health Simi Valley se enorgullece en anunciar la apertura de su clnica de nuevo diseo, un gran paso adelante para proporcionar atencin mdica accesible y de alta calidad a la comunidad.Esta nueva instalacin combina dos clnicas anteriores en una ubicacin simplificada, lo que aumenta la eficiencia, mejora el flujo de pacientes y ampla el acceso a la atencin primaria y especializada.